Cytokinetics
CYTK
#2440
Rank
S$9.12 B
Marketcap
S$65.51
Share price
-1.32%
Change (1 day)
-22.66%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2026 (TTM): S-$7.76

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is S-$7.79. In 2025 the company made an earnings per share (EPS) of S-$8.42 a decrease over its 2024 EPS that were of S-$6.79.

EPS history for Cytokinetics from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S-$7.76-7.85%
2025S-$8.4224.14%
2024S-$6.79-3.49%
2023S-$7.0328.24%
2022S-$5.4850.18%
2021S-$3.6540.8%
2020S-$2.59
2018S-$2.52-24.12%
2017S-$3.32-776.32%
2016S$0.49-139.18%
2015S-$1.25125.58%
2014S-$0.55-67.67%
2013S-$1.72-44.58%
2012S-$3.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$22.42-387.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
S-$44.81 475.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$3.34-142.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S-$64.90 732.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S-$1.48-80.96%๐Ÿ‡บ๐Ÿ‡ธ USA